← Open Payments lookup

GABRIEL NILES: Open Payments

NPI 1285611699 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$756 in 31 payments from 15 companies in 2025. Trend: 2023 $503 · 2024 $791 · 2025 $756

Food & beverage: $756
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.7$161
Lilly USA, LLC4$97
ABBVIE INC.3$78
Novo Nordisk Inc3$67
Madrigal Pharmaceuticals2$46
Tandem Diabetes Care, Inc.1$43
Sumitomo Pharma America, Inc.2$42
Boston Scientific Corporation1$37
Xeris Pharmaceuticals, Inc.2$32
Aimmune Therapeutics, Inc.1$32

Products named: Kerendia, MOUNJARO, REZDIFFRA, t:slim X2 Insulin Pump with Control-IQ, GEMTESA, WaveWriter Alpha Prime 16, GVOKE HYPOPEN, VOWST.

Industry payments across CA — which companies pay providers there.